Methylene blue and Alzheimer's disease
The relationship between methylene blue (MB) and Alzheimer's disease (AD) has recently
attracted increasing scientific attention since it has been suggested that MB may slow down …
attracted increasing scientific attention since it has been suggested that MB may slow down …
Loganin improves learning and memory impairments induced by scopolamine in mice
Loganin is an iridoid glycoside found in the Flos lonicerae, Fruit cornus, and Strychonos nux
vomica. We investigated the effect of loganin on learning and memory impairments induced …
vomica. We investigated the effect of loganin on learning and memory impairments induced …
Cholinesterase inhibitors from Sargassum and Gracilaria gracilis: Seaweeds inhabiting South Indian coastal areas (Hare Island, Gulf of Mannar)
S Natarajan, KP Shanmugiahthevar… - Natural Product …, 2009 - Taylor & Francis
Dementia is a chronic progressive mental disorder, which adversely affects memory,
thinking, comprehension, calculation and language. Some of the commonest forms of …
thinking, comprehension, calculation and language. Some of the commonest forms of …
Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as …
SS Chaudhaery, KK Roy… - Journal of chemical …, 2009 - ACS Publications
In view of the nonavailability of complete X-ray structure of carbamates cocrystallized with
AChE enzyme, the 3D-QSAR model development based on cocrystallized conformer …
AChE enzyme, the 3D-QSAR model development based on cocrystallized conformer …
Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice
RS Naik, J Hartmann, C Kiewert… - … of Pharmacy & …, 2009 - journals.library.ualberta.ca
Purpose. Alzheimers disease is characterized by a dysfunction of central cholinergic
systems and is treated by inhibitors of acetylcholinesterase (AChE). This study tests the …
systems and is treated by inhibitors of acetylcholinesterase (AChE). This study tests the …
Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors
E Luttmann, J Ludwig, A Höffle‐Maas… - ChemMedChem …, 2009 - Wiley Online Library
Current treatments of Alzheimer's disease include the allosteric potentiation of nicotinic
acetylcholine receptor (nAChR) response. The location of the binding site for allosteric …
acetylcholine receptor (nAChR) response. The location of the binding site for allosteric …
Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice
JMM Ezoulin, B Shao, Z Xia, Q Xie, J Li… - International Journal …, 2009 - academic.oup.com
Amyloid-β-induced neuroinflammation plays a central role in the extensive loss of
cholinergic neurons and cognitive decline in Alzheimer's disease. The acetylcholinesterase …
cholinergic neurons and cognitive decline in Alzheimer's disease. The acetylcholinesterase …
Electrophoretically mediated microanalysis technique as a tool for the rapid screening of novel acetylcholinesterase inhibitors
M Bajda, A Więckowska, B Malawska - Acta Poloniae Pharmaceutica …, 2009 - ruj.uj.edu.pl
An electrophoretically mediated microanalysis technique was developed for the rapid
screening of acetylcholinesterase inhibitors. Activity of four original compounds, N …
screening of acetylcholinesterase inhibitors. Activity of four original compounds, N …
Effect of distigmine bromide on the central cholinergic system
K Nakayama, H Katsu… - Journal of …, 2009 - journals.sagepub.com
Abstract Distigmine bromide (3, 3'-[hexamethylenebis (methyliminocarbonyloxy)] bis (1-
methylpyridinium) dibromide), an acetylcholinesterase (AChE) inhibitor, produced a time …
methylpyridinium) dibromide), an acetylcholinesterase (AChE) inhibitor, produced a time …
Estudos de Actividade Inibidora de Acetilcolinesterase e Actividade Antioxidante por Derivados de Colina de áCidos Cafeico, Cinâmico e Rosmarínico: Metabolismo …
SIP Santos - 2009 - search.proquest.com
A doença de Alzheimer (AD) é considerada a forma mais comum de demência na
população idosa. O cérebro de um doente de AD é caracterizado por uma deficiência na …
população idosa. O cérebro de um doente de AD é caracterizado por uma deficiência na …